CRC Honey Bee Products

Honey bee venom selectively targets breast cancer


CRC for Honey Bee Products research has contributed to the discovery of new compounds in bee venom to treat aggressive types of breast cancer. Melittin, a component of honey bee venom, can suppress the growth of breast cancer cells, particularly aggressive triple-negative breast cancer. The CRC has identified an additional venom compound that protects the surrounding normal cells.